Gesamtlänge aller Episoden: 10 days 18 hours 42 minutes
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data
Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?
Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?
Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist
Novel Therapies for Patients With DLBCL: What Does the Future Hold?
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
Evaluating the Evidence for SGLT2 Inhibition in CKD
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
A Look at Emerging SMA Outcomes: Highlights of CureSMA 2020